Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MARK3 | P27448 | 12/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | SGK1 | O00141 | 1/20 | 0.51 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.51 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.51 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.51 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.51 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.51 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.51 |
| ▸ | JAK2 | O60674 | 1/20 | 0.51 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.51 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | RAF1 | P04049 | 1/20 | 0.51 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5410365 | 0.82 | MMP12 (0.61) | MARK3HTTSGK1PIK3CDCHEK1 | |
| SCHEMBL5418877 | 0.82 | MARK3 (0.67) | MARK3SGK1PIK3CDCHEK1MAPK13 | |
| SCHEMBL5408669 | 0.81 | MARK3 (0.62) | MARK3SGK1PIK3CDCHEK1MAPK13 | |
| SCHEMBL5418238 | 0.81 | MARK3 (0.60) | MARK3SGK1PIK3CDCHEK1MAPK13 | |
| SCHEMBL5416556 | 0.79 | MARK3 (0.68) | MARK3HTTSGK1PIK3CDCHEK1 | |
| SCHEMBL5405711 | 0.77 | MARK3 (0.57) | MARK3SGK1PIK3CDCHEK1MAPK13 | |
| SCHEMBL5414309 | 0.76 | KDR (0.60) | MARK3SGK1PIK3CDCHEK1MAPK13 | |
| SCHEMBL5403017 | 0.75 | KDR (0.57) | MARK3SGK1PIK3CDCHEK1MAPK13 | |
| SCHEMBL5410676 | 0.74 | MARK3 (0.61) | MARK3SGK1PIK3CDCHEK1MAPK13 | |
| SCHEMBL5406806 | 0.74 | KDR (0.56) | MARK3SGK1PIK3CDCHEK1MAPK13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7262199-B2 | Tyrosine kinase inhibitors | MERCK & CO., INC. (US) | 2007-08-28 | — | — | US | claimed |
| US-20060183755-A1 | Tyrosine kinase inhibitors | MERCK SHARP & DOHME CORP. | 2006-08-17 | — | — | US | claimed |
| WO-2004052286-A2 | TYROSINE KINASE INHIBITORS | MERCK & CO., INC. (US) | 2004-06-24 | — | — | WO | claimed |
| US-7262199-B2 | Tyrosine kinase inhibitors | MERCK & CO., INC. (US) | 2007-08-28 | — | — | US | disclosed |
| US-7262199-B2 | Tyrosine kinase inhibitors | MERCK & CO., INC. (US) | 2007-08-28 | — | — | US | disclosed |
| US-7262199-B2 | Tyrosine kinase inhibitors | MERCK & CO., INC. (US) | 2007-08-28 | — | — | US | disclosed |
| US-20060183755-A1 | Tyrosine kinase inhibitors | MERCK SHARP & DOHME CORP. | 2006-08-17 | — | — | US | disclosed |
| WO-2004052286-A2 | TYROSINE KINASE INHIBITORS | MERCK & CO., INC. (US) | 2004-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060183755-A1 | Tyrosine kinase inhibitors | FLT1, FLT4, KDR | MARK3 304/4885LMNA 3576/4885HTT 3035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.